240 per cent growth in net profit: This small-cap stock announced robust results! 240 per cent growth in net profit: This small-cap stock announced robust results! The company has an impressive client list which includes Intas, Mankind and Indoco Remedies, among others. Siddharth Mane / Wednesday, May 31, 2023 / Article rating: 3.7 The company achieved a sales growth of 38 per cent (CAGR) over the span of three years, while its profit witnessed a remarkable growth of 246 per cent (CAGR) during the past 3 years.
IPO Analysis: Mankind Pharma Limited IPO IPO Analysis: Mankind Pharma Limited IPO IPO Rating: Apply for long term Shashikant Singh / Tuesday, April 25, 2023 / Article rating: 4.4 The price band of the issue has been fixed at Rs 1026 to Rs 1080 per equity share.